Mouse Immune Cell Specific Depletion Antibodies
Cell-specific depletion refers to the selective removal or reduction of a specific type of cell within a population. This process can be achieved through various techniques such as genetic manipulation, antibody-based methods, or pharmacological inhibitors. The goal of cell-specific depletion is to study the function and contribution of specific cell types to the overall physiology of a tissue or organism. This approach has been widely used in the field of biological research to gain insights into cellular signaling pathways, disease pathogenesis, and to test potential therapeutic strategies.
Cell-specific depletion using antibodies involves targeting a specific cell type with an antibody that recognizes a unique protein expressed on the surface or within the cell. The antibody can then bind to its target, leading to the removal of the cell through a process known as antibody-mediated cell death. This can occur via activation of the immune system, such as through complement-mediated cytotoxicity or antibody-dependent cellular phagocytosis, or through direct induction of apoptosis. Antibody-based cell depletion has been widely used in basic research to study the contribution of specific cell types to physiological processes, and in preclinical studies to evaluate potential therapeutic strategies. Some common examples of cell-specific depletion using antibodies include depletion of T cells in immunology research, depletion of cancer cells in oncology research, and depletion of neurons in neurobiology research.
Industry Leading Quality
Low-Endotoxin | Our mouse immune-cell-specific in vivo antibodies have the highest quality standards with low endotoxin levels and no detectable leachable protein A or aggregates. | |
High Purity | Purified by a multi-step process and are subjected to extensive QC to ensure high reproducibility between lots. | |
Formulation | No preservatives, stabilisers or carrier protein. Sterile PBS free from K+ or Ca2+. | |
Comprehensive | 45+ mouse immune-cell-specific functional-grade antibodies for research use. |
Browse All Products
T-Cells
Product Name | Reactivity | Clone | Application | Endotoxin Level |
---|---|---|---|---|
CD3ε [145-2C11] In Vivo Antibody | Mouse | 145-2C11 | Act, B, CODEX®, CyTOF®, Depletion, FA, FC, ICC, IF, IHC FF, WB | Low Endotoxin |
CD3ε [145-2C11] In Vivo Antibody | Mouse | 145-2C11 | Act, B, CODEX®, CyTOF®, Depletion, FA, FC, ICC, IF, IHC FF, WB | Ultra Low Endotoxin |
CD3ε [500A2] In Vivo Antibody | Mouse | 500A2 | B, FC, IHC FF | Low Endotoxin |
CD3ε [500A2] In Vivo Antibody | Mouse | 500A2 | B, FC, IHC FF | Ultra Low Endotoxin |
CD90 (Thy-1) [T24/31] In Vivo Antibody | Mouse | T24/31 | Depletion, FA, FC, WB | Ultra Low Endotoxin |
CD90 (Thy-1) [HK2.1] In Vivo Antibody | Mouse | HK2.1 | FA, WB | Ultra Low Endotoxin |
CD90 (Thy-1) [HK2.1] In Vivo Antibody | Mouse | HK2.1 | FA, WB | Low Endotoxin |
CD90 (Thy-1) [T24/31] In Vivo Antibody | Mouse | T24/31 | Depletion, FA, FC, WB | Low Endotoxin |
CD90.2 (Thy 1.2) In Vivo Antibody | Mouse | 30-H12 | CODEX®, Costim, CyTOF®, Depletion, FC, IHC FF, WB | Low Endotoxin |
CD90.2 (Thy-1.2) In Vivo Antibody | Mouse | 30-H12 | Costim, CyTOF®, Depletion, FC, IHC FF, WB | Ultra Low Endotoxin |
γ/δ (TCR) In Vivo Antibody | Mouse | UC7-13D5 | Depletion, FC, IP | Low Endotoxin |
γ/δ (TCR) In Vivo Antibody | Mouse | UC7-13D5 | Depletion, FC, IP | Ultra Low Endotoxin |
B-Cells
Product Name | Reactivity | Clone | Application | Endotoxin Level |
---|---|---|---|---|
CD45R [RA3-6B2] In Vivo Antibody | Mouse/Human | RA3-6B2 | Act, CODEX®, CyTOF®, Depletion, FA, FC, IHC FF, IP | Ultra Low Endotoxin |
CD45R [RA3-6B2] In Vivo Antibody | Mouse/Human | RA3-6B2 | Act, CODEX®, CyTOF®, Depletion, FA, FC, IHC FF, IP | Low Endotoxin |
CD19 In Vivo Antibody | Mouse | 1D3 | B, CODEX®, Depletion, FC, IHC FF, IP, WB | Low Endotoxin |
CD19 In Vivo Antibody | Mouse | 1D3 | B, CODEX®, Depletion, FC, IHC FF, IP, WB | Ultra Low Endotoxin |
CD4+ T-Cells
Product Name | Reactivity | Clone | Application | Endotoxin Level |
---|---|---|---|---|
CD45R [RA3-6B2] In Vivo Antibody | Mouse/Human | RA3-6B2 | Act, CODEX®, CyTOF®, Depletion, FA, FC, IHC FF, IP | Ultra Low Endotoxin |
CD45R [RA3-6B2] In Vivo Antibody | Mouse/Human | RA3-6B2 | Act, CODEX®, CyTOF®, Depletion, FA, FC, IHC FF, IP | Low Endotoxin |
CD19 In Vivo Antibody | Mouse | 1D3 | B, CODEX®, Depletion, FC, IHC FF, IP, WB | Low Endotoxin |
CD19 In Vivo Antibody | Mouse | 1D3 | B, CODEX®, Depletion, FC, IHC FF, IP, WB | Ultra Low Endotoxin |
CD8+ T-Cells
Product Name | Reactivity | Clone | Application | Endotoxin Level |
---|---|---|---|---|
CD8a (Ly 2) In Vivo Antibody | Mouse | 53-6.7 | B, CODEX®, CyTOF®, Depletion, FC, IHC FF, IP, WB | Low Endotoxin |
CD8a (Ly 2) In Vivo Antibody | Mouse | 53-6.7 | B, CODEX®, CyTOF®, Depletion, FC, IHC FF, IP, WB | Ultra Low Endotoxin |
CD8a (Ly 2.2) In Vivo Antibody | Mouse | 2.43 | Depletion, FA, FC, ICC, IF Staining, IHC FFPE, IP | Low Endotoxin |
CD8a (Ly 2.2) In Vivo Antibody | Mouse | 2.43 | Depletion, FA, FC, ICC, IF Staining, IHC FFPE, IP | Ultra Low Endotoxin |
CD8b.2 In Vivo Antibody | Mouse | 53-5.8 | Depletion, FA, FC, ICC, WB | Low Endotoxin |
CD8b.2 In Vivo Antibody | Mouse | 53-5.8 | Depletion, FA, FC, ICC, WB | Ultra Low Endotoxin |
CD8 In Vivo Antibody | Mouse | YTS-169 | Depletion, FC, IHC FF, WB | Low Endotoxin |
CD8 [YTS 169] In Vivo Antibody | Mouse | YTS-169 | Depletion, FC, IHC FF, WB | Ultra Low Endotoxin |
TReg-Cells
Product Name | Reactivity | Clone | Application | Endotoxin Level |
---|---|---|---|---|
CD25 In Vivo Antibody | Mouse | PC61 | B, CODEX®, Depletion, FA, FC, IHC FF, IP, WB | Low Endotoxin |
CD25 In Vivo Antibody | Mouse | PC61 | B, CODEX®, Depletion, FA, FC, IHC FF, IP, WB | Ultra Low Endotoxin |
γδ T-Cells
Product Name | Reactivity | Clone | Application | Endotoxin Level |
---|---|---|---|---|
TCR V gamma 2 In Vivo Antibody | Mouse | UC3-10A6 | Depletion, FC, IP | Low Endotoxin |
Vγ2 TCR In Vivo Antibody | Mouse | UC3-10A6 | Depletion, FC, IP | Ultra Low Endotoxin |
NK Cells
Product Name | Reactivity | Clone | Application | Endotoxin Level |
---|---|---|---|---|
NK1.1 In Vivo Antibody | Mouse | PK136 | B, CyTOF®, Depletion, FC, IP, WB | Low Endotoxin |
NK1.1 In Vivo Antibody | Mouse | PK136 | B, CyTOF®, Depletion, FC, IP, WB | Ultra Low Endotoxin |
Innate Lymphoid Cell
Product Name | Reactivity | Clone | Application | Endotoxin Level |
---|---|---|---|---|
Ly-6G/Ly-6C (Gr-1) In Vivo Antibody | Mouse | RB6-8C5 | CyTOF®, Depletion, IHC FF, IP, WB | Low Endotoxin |
Ly-6G/Ly-6C (Gr-1) In Vivo Antibody | Mouse | RB6-8C5 | CyTOF®, Depletion, FC, IHC FF, IHC FFPE, IP, WB | Ultra Low Endotoxin |
CD115 In Vivo Antibody | Mouse | AFS98 | B, CyTOF®, Depletion, FA, FC | Low Endotoxin |
CD115 (CSF-1R) In Vivo Antibody | Mouse | AFS98 | B, CyTOF®, Depletion, FA, FC | Ultra Low Endotoxin |
Macrophages
Product Name | Reactivity | Clone | Application | Endotoxin Level |
---|---|---|---|---|
CD115 In Vivo Antibody | Mouse | AFS98 | B, CyTOF®, Depletion, FA, FC | Low Endotoxin |
CD115 (CSF-1R) In Vivo Antibody | Mouse | AFS98 | B, CyTOF®, Depletion, FA, FC | Ultra Low Endotoxin |
CD209b In Vivo Antibody | Mouse | 22D1 | B, FC, IHC FF, WB | Low Endotoxin |
CD209b In Vivo Antibody | Mouse | 22D1 | B, FC, IHC FF, WB | Ultra Low Endotoxin |
Neutrophils
Product Name | Reactivity | Clone | Application | Endotoxin Level |
---|---|---|---|---|
Ly-6G In Vivo Antibody | Mouse | 1A8 | CODEX®, CyTOF®, Depletion, FC, IHC FF, WB | Low Endotoxin |
Ly-6G In Vivo Antibody | Mouse | 1A8 | CODEX®, CyTOF®, Depletion, FC, IHC FF, WB | Ultra Low Endotoxin |
Ly-6G/Ly-6C (Gr-1) In Vivo Antibody | Mouse | RB6-8C5 | CyTOF®, Depletion, IHC FF, IP, WB | Low Endotoxin |
Ly-6G/Ly-6C (Gr-1) In Vivo Antibody | Mouse | RB6-8C5 | CyTOF®, Depletion, FC, IHC FF, IHC FFPE, IP, WB | Ultra Low Endotoxin |
Low Vs. Ultra Low in vivo Antibody Quality Standards
FAQs
What is immune cell depletion?
It's the selective removal or reduction of an immune cell type such as T-cells, B-cells, NK cells and other cell types.
How do you deplete cells?
Using various means such as genetic manipulation, pharmacological inhibitors and/or antibody antibody-based methods such as antibody-dependent cellular phagocytosis (ADCP), antibody-dependent cellular cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC).
Why do you deplete cells?
To understand the function & role of specific cell types especially immune cells.
When has cell depletion been used?
This approach has been widely used in the field of immunology and cancer to gain insights into cellular signaling pathways, disease pathogenesis, and to test potential therapeutic strategies.
What are the key examples?
T-cell depletion in cancer studies, B-cell depletion in autoimmune disease and many more in mouse and in human studies.